Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Fondazione Neoplasie Sangue Onlus.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Fondazione Neoplasie Sangue Onlus
ClinicalTrials.gov Identifier:
NCT01166113
First received: July 16, 2010
Last updated: March 21, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2013
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
No publications provided by Fondazione Neoplasie Sangue Onlus

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):